The number one Bio Farma, the national pharmaceutical company, estimates that Indonesia needs to build a solid foundation in the area of research if it wants to be "independent in terms of vaccines," reported The Jakarta Post. Since 1997, Indonesia is one of the few Asian countries to make massive amounts of vaccines, including DTP-HB (diphtheria, tetanus, pertussis, hepatitis B), BCG (Bacille Calmette-Guerin against tuberculosis) and OPV (oral polio vaccine), and export them in 110 countries.
But all are produced on the basis of research conducted by Australian laboratories, Japanese, Dutch and South African, so that Bio Farma must repay their 5% royalty on all vaccines sold. Bio Farma for the moment that invests $ 11.7 million [8.1 million] a year in research and has fallen behind on future vaccines, such as the one against cancer. 
But all are produced on the basis of research conducted by Australian laboratories, Japanese, Dutch and South African, so that Bio Farma must repay their 5% royalty on all vaccines sold. Bio Farma for the moment that invests $ 11.7 million [8.1 million] a year in research and has fallen behind on future vaccines, such as the one against cancer.
- Which vaccinations can I ask for at my annual physical if I am traveling? (02/04/2011)
- At what age can children receive the flu vaccine? (18/12/2010)
- Study Finds Positive Association Between Autism and Vaccines (06/06/2011)
- Why are flu vaccinations produced from dead virus and not live viruses (05/06/2011)
- How can you make a flu vaccine out if tobacco plants (05/06/2011)
No comments:
Post a Comment